Skip to main content
Amir M. Arain
( out of 103 reviews )

Amir M. Arain, MD, MPH

Languages spoken: Arabic, Urdu, English

Clinical Locations

  • Dr. Amir M. Arain is a professor and an epileptologist that focuses on treatment of refractory epilepsy. He graduated from Dow Medical College, Karachi and did his Neurology residency and Epilepsy fellowship at Vanderbilt University. There he served on the faculty of Department of Neurology as an epileptologist from 2000-2018. He joined University of Utah in July 2018 and currently serves as chief of Epilepsy division.

    Dr. Arain has been involved in different research projects in epilepsy. He has done several antiepileptic drug trials including levetiracetam, oxcarbazepine, pregabalin, lacosemide, retigabine, brivaracetam, carisbamate, eslicarbazepine and cenobamate. He has published several peer reviewed research articles and has presented data in different scientific meetings. He has trained more than 100 fellows in epilepsy over the years. His interest is in seizure semiology, SUDEP, disparity of care in epilepsy and Geriatric epilepsy.

    Specialties

    Board Certification

    American Board of Clinical Neurophysiology
    American Board of Psychiatry & Neurology (Neurology)
    American Board of Psychiatry & Neurology (Sub: Clinical Neurophysiology)
    American Board of Psychiatry & Neurology (Sub: Epilepsy)

    Patient Rating

    4.6 /5
    ( out of 103 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 23, 2023
    CLINICAL NEUROSCIENCES CENTER

    Was having some bad side effects from a seizure medication I was on. Doctor Arian got me in to see him straight away that afternoon. I told him what was going on and he helped get me switched to a better medicine to manage my seizures with. This guy rocks! So grateful to have him as my doctor. He is a very busy man, so Im grateful that he cares about his patients so much. He even got me in to see Psichiatry after our visit, where I was able to get even more help with my side effects. 2 days into the new medication and Im feeling so much better. My appetite is starting to come back, Im sleeping better, Im feeling safe again. Thank you for helping me Dr. Arian, and also Lance, Sam, Eli, and everyone else on the ER staff!

    August 19, 2023
    CLINICAL NEUROSCIENCES CENTER

    He has made a big impact in our medical care for the positive! Very grateful for him and his staff

    August 16, 2023
    CLINICAL NEUROSCIENCES CENTER

    Dr. Arain was very personable.

    August 04, 2023
    CLINICAL NEUROSCIENCES CENTER

    Muy Profesional, sientansen orgullosos de tenerlo en su equipo

    July 20, 2023
    CLINICAL NEUROSCIENCES CENTER

    Positive impact on our sons health and well-being.

    July 13, 2023
    CLINICAL NEUROSCIENCES CENTER

    I was pleased by the thoughtful and attentive concern Doctor Arain approached my medical issue with. The initial visit was transparent and to the point leaving me feeling confident with the Doctor's plan for treatments and follow-up care.

    May 19, 2023
    CLINICAL NEUROSCIENCES CENTER

    He is great doctor and had a lot of experience in medical education and taking care of his patients

    May 11, 2023
    CLINICAL NEUROSCIENCES CENTER

    He makes me feel very comfortable and relaxed. Wish I could clone him to my PCP

    May 11, 2023
    CLINICAL NEUROSCIENCES CENTER

    JUST WONDERFUL......

  • Dr. Amir M. Arain is a professor and an epileptologist that focuses on treatment of refractory epilepsy. He graduated from Dow Medical College, Karachi and did his Neurology residency and Epilepsy fellowship at Vanderbilt University. There he served on the faculty of Department of Neurology as an epileptologist from 2000-2018. He joined University of Utah in July 2018 and currently serves as chief of Epilepsy division.

    Dr. Arain has been involved in different research projects in epilepsy. He has done several antiepileptic drug trials including levetiracetam, oxcarbazepine, pregabalin, lacosemide, retigabine, brivaracetam, carisbamate, eslicarbazepine and cenobamate. He has published several peer reviewed research articles and has presented data in different scientific meetings. He has trained more than 100 fellows in epilepsy over the years. His interest is in seizure semiology, SUDEP, disparity of care in epilepsy and Geriatric epilepsy.

    Board Certification and Academic Information

    Academic Departments Neurology -Primary
    Board Certification
    American Board of Clinical Neurophysiology
    American Board of Psychiatry & Neurology (Neurology)
    American Board of Psychiatry & Neurology (Sub: Clinical Neurophysiology)
    American Board of Psychiatry & Neurology (Sub: Epilepsy)

    Education history

    Graduate Training Epidemiology, Biostatistics, Clinical Research Design, etc - Vanderbilt University M.P.H.
    Epilepsy/Neurophysiology - Vanderbilt University Medical Center Clinical Fellow
    Chief Resident Neurology - Vanderbilt University Medical Center Chief Resident
    Neurology - Vanderbilt University Medical Center Resident
    Internship Internal Medicine - McLaren Flint Intern
    Medicine, Surgery - Dow Medical College of the University of Karachi M.B.B.S.

    Selected Publications

    Journal Article

    1. Anderson DN, Charlebois CM, Smith EH, Davis TS, Peters AY, Newman BJ, Arain AM, Wilcox KS, Butson CR, Rolston JD (2023). Closed-loop stimulation in periods with less epileptiform activity drives improved epilepsy outcomes. Brain. (Read full article)
    2. Campbell JM, Kundu B, Lee JN, Miranda M, Arain A, Taussky P, Grandhi R, Rolston JD (2022). Evaluating the concordance of functional MRI-based language lateralization and Wada testing in epilepsy patients: A single-center analysis. Interv Neuroradiol, 29(5), 599-604. (Read full article)
    3. Simon A, Nguyen D, Newman B, Arain A (2023). Uric Acid Nephropathy Secondary to Generalized Tonic-Clonic Seizures. Neurologist. (Read full article)
    4. Kundu B, Arain A, Davis T, Charlebois CM, Rolston JD (2022). Using chronic recordings from a closed-loop neurostimulation system to capture seizures across multiple thalamic nuclei. Ann Clin Transl Neurol, 10(1), 136-143. (Read full article)
    5. Charlebois CM, Anderson DN, Johnson KA, Philip BJ, Davis TS, Newman BJ, Peters AY, Arain AM, Dorval AD, Rolston JD, Butson CR (2022). Patient-specific structural connectivity informs outcomes of responsive neurostimulation for temporal lobe epilepsy. Epilepsia, 63(8), 2037-2055. (Read full article)
    6. Miranda M, Arias F, Arain A, Newman B, Rolston J, Richards S, Peters A, Pick LH (2022). Neuropsychological evaluation in American Sign Language: A case study of a deaf patient with epilepsy. Epilepsy Behav Rep, 19, 100558. (Read full article)
    7. Brown MG, Sillau S, McDermott D, Ernst LD, Spencer DC, Englot DJ, Gonzlez HFJ, Datta P, Karakis I, Becker D, Rolston JD, Arain A, Rao VR, Doherty M, Urban A, Drees C (2022). Concurrent brain-responsive and vagus nerve stimulation for treatment of drug-resistant focal epilepsy. Epilepsy Behav, 129, 108653. (Read full article)
    8. Anderson DN, Charlebois CM, Smith EH, Arain AM, Davis TS, Rolston JD (2021). Probabilistic comparison of gray and white matter coverage between depth and surface intracranial electrodes in epilepsy. Sci Rep, 11(1), 24155. (Read full article)
    9. Jehi L, Morita-Sherman M, Love TE, Bartolomei F, Bingaman W, Braun K, Busch RM, Duncan J, Hader WJ, Luan G, Rolston JD, Schuele S, Tassi L, Vadera S, Sheikh S, Najm I, Arain A, Bingaman J, Diehl B, de Tisi J, Rados M, Van Eijsden P, Wahby S, Wang X, Wiebe S (2021). Comparative Effectiveness of Stereotactic Electroencephalography Versus Subdural Grids in Epilepsy Surgery. Ann Neurol, 90(6), 927-939. (Read full article)
    10. Frankel MA, Lehmkuhle MJ, Spitz MC, Newman BJ, Richards SV, Arain AM (2021). Wearable Reduced-Channel EEG System for Remote Seizure Monitoring. Front Neurol, 12, 728484. (Read full article)
    11. Scoville JP, Joyce E, Hunsaker J, Reese J, Wilde H, Arain A, Bollo RL, Rolston JD (2020). Stereotactic Electroencephalography Is Associated With Reduced Pain and Opioid Use When Compared with Subdural Grids: A Case Series. Oper Neurosurg (Hagerstown), 21(1), 6-13. (Read full article)
    12. Kundu B, Davis TS, Philip B, Smith EH, Arain A, Peters A, Newman B, Butson CR, Rolston JD (2020). A systematic exploration of parameters affecting evoked intracranial potentials in patients with epilepsy. Brain Stimul, 13(5), 1232-1244. (Read full article)
    13. Bornali Kundu, Tyler S Davis, Brian Philip, Elliot H Smith, Amir Arain, Angela Peters, Blake Newman, Christopher R Butson, John D Rolston (2020). A systematic exploration of parameters affecting evoked intracranial potentials in patients with epilepsy. Brain Stimul, 13(5), 1232-1244.
    14. Zaher N, Haas K, Sonmezturk H, Arain A, Abou-Khalil B (2019). Rhythmic ictal nonclonic hand (RINCH) motions in general EMU patients with focal epilepsy. Epilepsy Behav, 103(Pt A), 106666. (Read full article)
    15. Naoir Zaher, Kevin Haas, Hasan Sonmezturk, Amir Arain, Bassel Abou-Khalil (2019). Rhythmic ictal nonclonic hand (RINCH) motions in general EMU patients with focal epilepsy. Epilepsy Behav, Feb. 2020, 103 pt. A.
    16. Arain AM, Umar A, Rawal P, Azar NJ, Obideen M, Singh P, Al-Kaylani M, Abou-Khalil B (2018). Localization value of ictal turning prone. Seizure, 69, 57-60. (Read full article)
    17. Halford JJ, Westover MB, LaRoche SM, Macken MP, Kutluay E, Edwards JC, Bonilha L, Kalamangalam GP, Ding K, Hopp JL, Arain A, Dawson RA, Martz GU, Wolf BJ, Waters CG, Dean BC (2018). Interictal Epileptiform Discharge Detection in EEG in Different Practice Settings. J Clin Neurophysiol, 35(5), 375-380. (Read full article)
    18. Baker MD, Abou-Khalil BW, Arain A, Tummala P, Azar NJ, Haas KF, Sonmezturk HH (2018). Lacosamide efficacy and tolerability in clinical practice - Post marketing analysis from a single dedicated epilepsy center. Clin Neurol Neurosurg, 171, 179-183. (Read full article)
    19. Sagi V, Kim I, Bhatt AB, Sonmezturk H, Abou-Khalil BW, Arain AM (2017). Generalized paroxysmal fast activity in EEG: An unrecognized finding in genetic generalized epilepsy. Epilepsy Behav, 76, 101-104. (Read full article)
  • News & Podcasts